Seeking Alpha

Receptos prices stock offering

  • Receptos (RCPT) prices its public offering of 4,433,000 shares of common stock at $40.25/share. Underwriters over-allotment is 664,950 shares. Closing date is June 24.
  • Net proceeds will be used to fund the continued development of RPC1063 in clinical trials for relapsing multiple sclerosis and ulcerative colitis, the development of its in-licensed product candidate RPC4046 for eosinophilic esophagitis, other research programs and for general corporate purposes.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: